FORTIS Fortis Healthcare Q1 FY27 results (Apr–Jun 2026) and concall
Fortis Healthcare reported a steady Q1 FY27 performance with consolidated revenue growing 17.5% to INR 2,545 crores. The hospital business saw a 19% revenue increase and improved ARPOB, while the diagnostics segment grew 10.2% with margin expansion. Despite a slight consolidated EBITDA margin dip (pre-ESOP) and slower oncology growth due to pricing pressures, the company is focused on strategic bed expansion, network growth, and operational efficiencies, targeting a 25% EBITDA margin by FY28.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 12.9%, net profit down 7.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 357 | 367 | 388 | 433 | 456 +28% | 443 +21% | 461 +19% | 489 +13% |
| EBITDA | 60 | 67 | 71 | 88 | 100 +67% | 99 +48% | 110 +55% | 104 +18% |
| Net profit | 40 | 40 | -42 | 52 | 125 +213% | 28 −30% | 25 +160% | 48 −8% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





